general
- Generic Name : Abarelix
- Pronunciation : ab-ah-REL-ix
- ICD Code : Y43.3
- Therapeutic Classification : Chemotherapy
- International : Plenaxis
prescription
- Abarelix is employed in the treatment of prostate cancer to reduce symptoms and enhance the quality of life in patients.
- It works by impacting the secretion of testosterone in the body, thereby impeding the growth of prostate cancer.
risk factors
- Risk in women, children and individuals with known hypersensitivity.
side effects
- Genitourinary : Hot flushes, pain, breast enlargement, breast pain/nipple tenderness, painful urination, urination frequency, nausea, urinary retention and urinary tract infection.
- Central Nervous System : Sleep disturbances, dizziness, syncope, headache, and fatigue.
- Heart – Hypotension, peripheral edema.
- Miscellaneous : Allergic reactions, back pain, constipation, swelling in the extremities, temporary redness of face and neck, upper respiratory tract infection and diarrhea.
dosage
IM- The recommended dose is 100 mg on day 1, 15, 29 (week 4) and every 4 weeks thereafter.
how to take
- It comes as a solution for injection to be administered by a healthcare provider into the buttock.
warning
- Caution is advised in patients with a history of heart disease, including long QT syndrome and abnormal heart rhythm, as well as in individuals with liver disease.
- It is important to be cautious when taking other medications, have known allergies, or during breastfeeding.
- This medication may induce dizziness, so it is recommended to refrain from driving a car or operating machinery while under its influence.
- Regular monitoring of testosterone blood levels, prostate-specific antigen (PSA), and liver function tests is advised while taking this medication.
storage
As directed by your physician